Nutrien Ltd. (TSX:NTR)
Canada · Delayed Price · Currency is CAD 94.70
+0.80 (0.85%)
Aug 14, 2026, 4:00 PM EST
Nutrien Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 27,288 | 25,949 | 25,016 | 28,082 | 37,012 | 26,861 | |
Revenue Growth | 9.06% | 3.73% | -10.92% | -24.13% | 37.79% | 33.95% |
Cost of Revenue | 18,539 | 17,602 | 17,486 | 19,608 | 21,588 | 17,452 |
Gross Profit | 8,749 | 8,347 | 7,530 | 8,474 | 15,424 | 9,409 |
Selling, General & Admin | 4,049 | 3,924 | 4,084 | 4,108 | 3,987 | 3,628 |
Other Operating Expenses | 869 | 790 | 816 | 827 | 1,534 | 737 |
Operating Expenses | 5,065 | 4,877 | 4,937 | 4,921 | 5,584 | 4,563 |
Operating Income | 3,684 | 3,470 | 2,593 | 3,553 | 9,840 | 4,846 |
Interest Expense | -690 | -675 | -683 | -726 | -484 | -463 |
Interest & Investment Income | 51 | 51 | 28 | 35 | 25 | 8 |
Earnings From Equity Investments | 29 | 37 | 130 | 101 | 247 | 89 |
Currency Exchange Gain (Loss) | 4 | -9 | -360 | -91 | -31 | -42 |
Other Non Operating Income (Expenses) | -59 | -59 | -60 | -97 | -96 | -7 |
EBT Excluding Unusual Items | 3,019 | 2,815 | 1,648 | 2,775 | 9,501 | 4,431 |
Merger & Restructuring Charges | -128 | -68 | -47 | -49 | -46 | -43 |
Gain (Loss) on Sale of Investments | 301 | 301 | - | - | 19 | - |
Asset Writedown | -30 | - | -530 | -774 | 780 | -33 |
Other Unusual Items | - | - | - | - | -8 | -187 |
Pretax Income | 3,163 | 3,049 | 1,136 | 1,952 | 10,246 | 4,168 |
Income Tax Expense | 753 | 752 | 436 | 670 | 2,559 | 989 |
Earnings From Continuing Operations | 2,410 | 2,297 | 700 | 1,282 | 7,687 | 3,179 |
Net Income to Company | 2,410 | 2,297 | 700 | 1,282 | 7,687 | 3,179 |
Minority Interest in Earnings | -30 | -30 | -26 | -24 | -27 | -26 |
Net Income | 2,380 | 2,267 | 674 | 1,258 | 7,660 | 3,153 |
Net Income to Common | 2,380 | 2,267 | 674 | 1,258 | 7,660 | 3,153 |
Net Income Growth | 74.61% | 236.35% | -46.42% | -83.58% | 142.94% | 586.93% |
Shares Outstanding (Basic) | 482 | 486 | 494 | 496 | 538 | 570 |
Shares Outstanding (Diluted) | 483 | 487 | 494 | 497 | 540 | 571 |
Shares Change | -1.75% | -1.59% | -0.53% | -7.97% | -5.47% | 0.28% |
EPS (Basic) | 4.93 | 4.66 | 1.36 | 2.53 | 14.23 | 5.53 |
EPS (Diluted) | 4.93 | 4.66 | 1.36 | 2.53 | 14.18 | 5.52 |
EPS Growth | 78.33% | 242.65% | -46.25% | -82.16% | 156.88% | 585.08% |
Free Cash Flow | 2,233 | 2,147 | 1,536 | 2,672 | 5,857 | 2,109 |
Free Cash Flow Per Share | 4.63 | 4.41 | 3.11 | 5.38 | 10.85 | 3.69 |
Dividend Per Share | 2.190 | 2.180 | 2.160 | 2.120 | 1.920 | 1.840 |
Dividend Growth | 0.92% | 0.93% | 1.89% | 10.42% | 4.35% | 2.22% |
Gross Margin | 32.06% | 32.17% | 30.10% | 30.18% | 41.67% | 35.03% |
Operating Margin | 13.50% | 13.37% | 10.37% | 12.65% | 26.59% | 18.04% |
Profit Margin | 8.72% | 8.74% | 2.69% | 4.48% | 20.70% | 11.74% |
Free Cash Flow Margin | 8.18% | 8.27% | 6.14% | 9.52% | 15.82% | 7.85% |
EBITDA | 5,651 | 5,412 | 4,512 | 5,334 | 11,513 | 6,490 |
EBITDA Margin | 20.71% | 20.86% | 18.04% | 18.99% | 31.11% | 24.16% |
D&A For EBITDA | 1,967 | 1,942 | 1,919 | 1,781 | 1,673 | 1,644 |
EBIT | 3,684 | 3,470 | 2,593 | 3,553 | 9,840 | 4,846 |
EBIT Margin | 13.50% | 13.37% | 10.37% | 12.65% | 26.59% | 18.04% |
Effective Tax Rate | 23.81% | 24.66% | 38.38% | 34.32% | 24.98% | 23.73% |